Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Alpha-tocopherol1件: Tocopherol1件: Tocopherol 💬 --2件: 49, 215 💬
2Blood draw----16件: 3, 6, 13, 19, 46, 48, 49, 51, 58, 65, 67, 193, 215, 231, 298, 299 💬
3Calcium1件: Calcium---39件: 2, 3, 6, 13, 15, 19, 46, 48, 49, 51, 53, 56, 62, 67, 68, 71, 74, 75, 79, 84, 90, 93, 94, 95, 96, 97, 156, 186, 214, 215, 222, 224, 235, 256, 265, 271, 274, 298, 299 💬
4Calcium gluconate2件: Calcium,
Calcium gluconate		1件: Calcium gluconate 💬 --3件: 214, 215, 235 💬
5Cardiac Magnetic Resonance Imaging (CMRI)----1件: 215 💬
6Cardiac MRI (CMR)----2件: 215, 216 💬
7Cellvizio 100 Series System with Confocal Miniprobes----1件: 215 💬
8Central venous line placement----1件: 215 💬
9Chest X-ray----1件: 215 💬
10Cold Cadioplegia----1件: 215 💬
11Dapagliflozin1件: Dapagliflozin1件: Dapagliflozin 💬 --16件: 6, 19, 28, 40, 41, 49, 57, 66, 67, 86, 88, 97, 210, 215, 218, 222 💬
12DEXMEDETOMIDINE1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬15件: 2, 4, 6, 21, 22, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬
13Dexmedetomidine Hcl 100 Mcg/mL Inj1件: Dexmedetomidine2件: Dexmedetomidine ,
Dexmedetomidine hydrochloride 💬 		3件: ADRA2A,
ADRA2B,
ADRA2C 💬 		4件: Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
14Dobutamin----1件: 215 💬
15Dobutamine1件: Dobutamine3件: Dobutamine hydrochloride ,
Dobutamine ,
Dobutamine tartrate 💬 		1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬5件: 28, 57, 58, 86, 215 💬
16Echocardiogram----3件: 19, 215, 216 💬
17Electrocardiogram----1件: 215 💬
18Eplerenone1件: Eplerenone1件: Eplerenone 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 💬5件: 57, 75, 113, 210, 215 💬
19Fentanyl1件: Fentanyl3件: Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬6件: 46, 70, 97, 215, 231, 298 💬
20Fentanyl (High Dose)1件: Fentanyl3件: Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 215 💬
21Fentanyl (Low Dose)1件: Fentanyl3件: Fentanyl ,
Fentanyl citrate ,
Fentanyl hydrochloride 💬 		1件: OPRM1 💬 5件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction 💬1件: 215 💬
22Fentanyl (Low Dose) + Dexmedetomidine2件: Dexmedetomidine,
Fentanyl		5件: Fentanyl ,
Dexmedetomidine ,
Dexmedetomidine hydrochloride ,
Fentanyl citrate ,
Fentanyl hydrochloride 💬 		4件: ADRA2A,
ADRA2B,
ADRA2C,
OPRM1 💬 		6件: Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬1件: 215 💬
23Fluid administration----1件: 215 💬
24Fluorescite----1件: 215 💬
25Gold1件: Gold---71件: 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
26HTK cardioplegia----1件: 215 💬
27KETAMINE1件: Ketamine2件: Ketamine hydrochloride ,
Ketamine 💬 		5件: GRIN1,
GRIN2A,
GRIN2B,
GRIN2C,
GRIN2D 💬 		21件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬6件: 6, 13, 70, 113, 156, 215 💬
28Losartan1件: Losartan2件: Losartan potassium ,
Losartan 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬20件: 17, 19, 36, 46, 57, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 223, 299 💬
29LOSARTAN POTASSIUM2件: Losartan,
Potassium		3件: Losartan potassium ,
Losartan ,
Potassium 💬 		1件: AGTR1 💬 17件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Hormone signaling, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 💬5件: 36, 98, 167, 179, 215 💬
30Other: blood cardioplegia----1件: 215 💬
31Other: del nido cardioplegia----1件: 215 💬
32Other: dobutamine1件: Dobutamine3件: Dobutamine hydrochloride ,
Dobutamine ,
Dobutamine tartrate 💬 		1件: ADRB1 💬 13件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 215 💬
33Other: N-thymidine1件: Thymidine1件: Doxribtimine 💬 1件: TK2 💬 2件: Drug metabolism - other enzymes, Pyrimidine metabolism 💬2件: 215, 216 💬
34Other: N15-thymidine1件: Thymidine1件: Doxribtimine 💬 1件: TK2 💬 2件: Drug metabolism - other enzymes, Pyrimidine metabolism 💬1件: 215 💬
35Other: Specimen Collection----2件: 215, 216 💬
36Other: Transthoracic echocardiography at rest, during PLR, HG and CPX (including blood gas analysis in both groups). Additionally Fallot patients will undergo routine blood testings.----1件: 215 💬
37Other: Urine Collection----2件: 215, 216 💬
38Physical Exam----2件: 215, 216 💬
39Potassium1件: Potassium1件: Potassium 💬 --17件: 36, 46, 57, 58, 66, 67, 88, 93, 94, 97, 98, 115, 167, 179, 215, 223, 235 💬
40Pregnancy test----2件: 50, 215 💬
41Propranolol1件: Propranolol2件: Propranolol hydrochloride ,
Propranolol 💬 		3件: ADRB1,
ADRB2,
ADRB3 💬 		14件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬7件: 6, 158, 167, 215, 216, 227, 278 💬
42Propranolol Hydrochloride1件: Propranolol2件: Propranolol hydrochloride ,
Propranolol 💬 		3件: ADRB1,
ADRB2,
ADRB3 💬 		14件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy, Gap junction, Hormone signaling, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, cAMP signaling pathway, cGMP-PKG signaling pathway 💬2件: 215, 216 💬
43Recombinant human brain natriuretic peptide (rhBNP)----1件: 215 💬
44SGLT2 inhibitor (Dapagliflozin 10mg)1件: Dapagliflozin1件: Dapagliflozin 💬 --1件: 215 💬
45SGLT2 inhibitors----3件: 208, 210, 215 💬
46Sodium chloride1件: Sodium chloride1件: Sodium chloride 💬 --31件: 2, 6, 11, 13, 14, 22, 34, 41, 46, 50, 51, 53, 60, 65, 67, 70, 85, 96, 97, 124, 168, 193, 214, 215, 226, 227, 228, 271, 288, 298, 299 💬
47Sodium citrate1件: Sodium citrate1件: Sodium citrate 💬 --4件: 67, 214, 215, 235 💬
48Sterile Water for Injection1件: Water1件: Water 💬 --1件: 215 💬
49SULFUR HEXAFLUORIDE1件: Sulfur hexafluoride1件: Sulfur hexafluoride 💬 --3件: 96, 97, 215 💬
50Sulfur Hexafluoride Lipid Type A Microspheres 25 MG Injection Powder for Suspension [LUMASON]1件: Sulfur hexafluoride1件: Sulfur hexafluoride 💬 --1件: 215 💬
51Thymidine1件: Thymidine1件: Doxribtimine 💬 1件: TK2 💬 2件: Drug metabolism - other enzymes, Pyrimidine metabolism 💬2件: 215, 216 💬
52Tocopherol1件: Tocopherol1件: Tocopherol 💬 --7件: 13, 49, 71, 206, 215, 257, 298 💬
53Tranexamic acid1件: Tranexamic acid1件: Tranexamic acid 💬 1件: PLG 💬 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 💬7件: 46, 65, 70, 215, 227, 274, 299 💬
54Water1件: Water1件: Water 💬 --36件: 2, 3, 5, 6, 13, 17, 19, 22, 35, 46, 49, 51, 53, 56, 57, 62, 63, 64, 65, 66, 67, 70, 72, 85, 86, 96, 97, 206, 215, 225, 226, 230, 240, 274, 278, 299 💬